Zobrazeno 1 - 10
of 1 685
pro vyhledávání: '"Rawson, TM"'
Publikováno v:
Infection and Drug Resistance, Vol Volume 16, Pp 2709-2726 (2023)
Timothy M Rawson,1– 3 David B Antcliffe,2,4 Richard C Wilson,1– 3 Alireza Abdolrasouli,5 Luke SP Moore1,6,7 1Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Hammersmith Hospital, London, UK; 2Cent
Externí odkaz:
https://doaj.org/article/95ac32d334eb46f2b0ad2d7ff2af139c
Autor:
Duangpraphat M; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Ratchadhevi, Bangkok, Thailand., Wilson RC; Centre for Antimicrobial Optimisation, Imperial College London, United Kingdom.; David Price Evans Global Health and Infectious Diseases Research Group, University of Liverpool, United Kingdom., Rawson TM; Centre for Antimicrobial Optimisation, Imperial College London, United Kingdom.; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital, London, United Kingdom; and., Santimaleeworagun W; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Ratchadhevi, Bangkok, Thailand.; Department of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakorn Pathom, Thailand., Nasomsong W; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Ratchadhevi, Bangkok, Thailand., Holmes AH; Centre for Antimicrobial Optimisation, Imperial College London, United Kingdom.; David Price Evans Global Health and Infectious Diseases Research Group, University of Liverpool, United Kingdom.; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital, London, United Kingdom; and., Vasikasin V; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Ratchadhevi, Bangkok, Thailand.; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital, London, United Kingdom; and.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2024 Oct 22. Date of Electronic Publication: 2024 Oct 22.
Autor:
Rawson TM; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK. Electronic address: timothy.rawson07@imperial.ac.uk., Zhu N; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK., Galiwango R; The African Centre of Excellence in Bioinformatics and Data Intensive Sciences, The Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Cocker D; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK., Islam MS; Child Health Research Foundation, Dhaka, Bangladesh., Myall A; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Centre for Mathematics of Precision Healthcare, Imperial College London, London, UK., Vasikasin V; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Division of Infectious Diseases, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand., Wilson R; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK., Shafiq N; Clinical Pharmacology Unit, Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Das S; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, The University of Liverpool, Liverpool Health Partners, Liverpool, UK., Holmes AH; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK.
Publikováno v:
The Lancet. Digital health [Lancet Digit Health] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.
Autor:
Lawrence J; The NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, London, United Kingdom. j.lawrence21@imperial.ac.uk.; Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom. j.lawrence21@imperial.ac.uk., O'Hare D; Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom.; Department of Bioengineering, Imperial College London, South Kensington Campus, London, United Kingdom., van Batenburg-Sherwood J; Department of Bioengineering, Sir Michael Uren Hub, Imperial College London, White City Campus, London, United Kingdom., Sutton M; Antimicrobial Discovery, Development and Diagnostics (AD3) UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom.; Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Holmes A; The NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, London, United Kingdom.; Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom.; David Price Evans Infectious Diseases and Global Health Group, University of Liverpool, Liverpool, United Kingdom., Rawson TM; The NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, London, United Kingdom.; Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 21; Vol. 15 (1), pp. 9070. Date of Electronic Publication: 2024 Oct 21.
Autor:
Blank M; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom. Electronic address: michael.blank@nhs.net., Wilson RC; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool L7 8TX, United Kingdom., Wan Y; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom., Peters J; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom., Davies F; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom., Tyszczuk L; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom., Pichon B; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom., Riezk A; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom., Demirjian A; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom; Department of Paediatric Infectious Disease & Immunology, Evelina London Children's Hospital, London, UK; Faculty of Life Sciences & Medicine, Kings College London, London, UK; Faculty of Medicine, Imperial College London, London, UK., Brown CS; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom., Gilchrist M; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom., Holmes AH; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool L7 8TX, United Kingdom., Rawson TM; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool L7 8TX, United Kingdom.
Publikováno v:
The Journal of infection [J Infect] 2024 Aug; Vol. 89 (2), pp. 106191. Date of Electronic Publication: 2024 Jun 05.
Autor:
Wilson RC; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK. richard.wilson@imperial.ac.uk.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK. richard.wilson@imperial.ac.uk.; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK. richard.wilson@imperial.ac.uk.; David Price Evans Infectious Diseases and Global Health Group, The University of Liverpool, Liverpool, L7 8TX, UK. richard.wilson@imperial.ac.uk., Riezk A; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK., Arkell P; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK., Ming D; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK., Armiger R; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK., Latham V; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK., Gilchrist MJ; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK.; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK., Märtson AG; Leiden Academic Centre for Drug Research, Leiden University, 2333 AL, Leiden, The Netherlands., Hope WW; Antimicrobial Pharmacodynamics and Therapeutics Group, The University of Liverpool, Liverpool, L7 8TX, UK., Holmes AH; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK.; David Price Evans Infectious Diseases and Global Health Group, The University of Liverpool, Liverpool, L7 8TX, UK., Rawson TM; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK.; David Price Evans Infectious Diseases and Global Health Group, The University of Liverpool, Liverpool, L7 8TX, UK.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jul 21; Vol. 14 (1), pp. 16762. Date of Electronic Publication: 2024 Jul 21.
Autor:
Kherabi Y; Infectious and Tropical Disease Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France. Electronic address: yousra.kherabi@aphp.fr., Thy M; Medical and Infectious Diseases ICU (MI2) - Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France; EA 7323 - Pharmacology and Therapeutic Evaluation in Children and Pregnant Women, Université Paris Cité, Paris, France., Bouzid D; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France; Emergency Department, Bichat Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France., Antcliffe DB; Division of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Intensive Care Unit, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Rawson TM; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Centre for Antimicrobial Optimisation Imperial College London, London, UK., Peiffer-Smadja N; Infectious and Tropical Disease Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Cité, Paris, France; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
Publikováno v:
Infectious diseases now [Infect Dis Now] 2024 Apr; Vol. 54 (3), pp. 104864. Date of Electronic Publication: 2024 Feb 12.
Publikováno v:
JAC-Antimicrobial Resistance. 5
The emergence of carbapenem-resistant organisms (CROs) is a significant global threat. Reduction of carbapenem consumption can decrease CROs. In the global endemic era of ESBL-producing bacteria, carbapenems are considered the treatment of choice, le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226065ecf0543376aae9688a18c6e46e
https://doi.org/10.1093/jacamr/dlad036
https://doi.org/10.1093/jacamr/dlad036
Autor:
Riezk A; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK. alaa.riezk@imperial.ac.uk., Wilson RC; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK. alaa.riezk@imperial.ac.uk.; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK.; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool, L7 8TX, UK., Cass AEG; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK. alaa.riezk@imperial.ac.uk.; Department of Chemistry, Molecular Sciences Research Hub, Imperial College, London, UK., Holmes AH; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK. alaa.riezk@imperial.ac.uk.; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool, L7 8TX, UK., Rawson TM; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, Acton, London, W12 0NN, UK. alaa.riezk@imperial.ac.uk.; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool, L7 8TX, UK.
Publikováno v:
Analytical methods : advancing methods and applications [Anal Methods] 2024 Jan 25; Vol. 16 (4), pp. 558-565. Date of Electronic Publication: 2024 Jan 25.
Autor:
Bolton WJ; Centre for Antimicrobial Optimisation, Imperial College London, London, UK. william.bolton@imperial.ac.uk.; AI4Health Centre for Doctoral Training, Imperial College London, London, UK. william.bolton@imperial.ac.uk.; Department of Computing, Imperial College London, London, UK. william.bolton@imperial.ac.uk.; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK. william.bolton@imperial.ac.uk., Wilson R; Centre for Antimicrobial Optimisation, Imperial College London, London, UK.; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.; Faculty of Health & Life Sciences, University of Liverpool, Liverpool, UK., Gilchrist M; Centre for Antimicrobial Optimisation, Imperial College London, London, UK.; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK., Georgiou P; Centre for Antimicrobial Optimisation, Imperial College London, London, UK.; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.; Centre for Bio-inspired Technology, Department of Electrical and Electronic Engineering, Imperial College London, London, UK., Holmes A; Centre for Antimicrobial Optimisation, Imperial College London, London, UK.; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.; Faculty of Health & Life Sciences, University of Liverpool, Liverpool, UK.; Department of Infectious Diseases, Imperial College London, London, UK., Rawson TM; Centre for Antimicrobial Optimisation, Imperial College London, London, UK.; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
Publikováno v:
Nature communications [Nat Commun] 2024 Jan 13; Vol. 15 (1), pp. 506. Date of Electronic Publication: 2024 Jan 13.